The One-Sentence Test: A Ten-Minute Diagnostic to Run Before Any Life Sciences Rebrand

A life sciences purchase is no longer explained to one person. Forrester puts the typical B2B buying decision at 13 internal stakeholders and nine external influencers, 22 people who have to arrive at roughly the same understanding of what a vendor does, most of them working from secondhand accounts rather than a meeting with the vendor.¹ Increasingly, a machine sits in that chain as well. The single sentence that describes a company is the one asset that has to survive being relayed across all of those readers intact, and most organizations do not have one. They have several, and do not know it.

There is a fast way to find out.

One sentence, four readers, four ways to fail

If the three answers differ, the problem is not design, messaging, or traffic. It is either an identity problem, an articulation problem, or a communication problem.

The sentence is unforgiving because it has four readers, and when it is absent it fails all four at once.

• The team builds every asset on a different guess, which is why the homepage, the sales one-pager, and the trade-show banner describe subtly different companies.
• The buyer, who arrives with a real need, will not do the work of deciding whether a vague page is relevant, and the visit ends. The cost of that vagueness is measurable: researchers from Gartner, writing in Harvard Business Review, found that buyers who judge a supplier's information helpful in advancing the purchase are about three times more likely to complete a larger, lower-regret deal.²
• The champion, the person selling the company inside a committee, cannot explain it to skeptics who have never heard of it.
• And the buyer's AI, asked who does X in a category, reads the same murky sentences with none of a human's willingness to fill the gap: 45% of B2B buyers have used generative AI to research vendors and products, and a model can only repeat a claim it can extract.³

The fix is subtraction, then specificity

Reaching the sentence is harder than the design work that usually follows, which is why teams skip it. The work is mostly subtraction. Cross out every word a competitor could also claim. "Innovative" goes; everyone says it. "Patient-centric" names an aspiration, not a difference. "Leading" is self-cancelling; the claim that has to be asserted is the one the market does not already grant. What survives is the smaller, harder kernel of what is true and specific to the company.

Then make it concrete, because clarity lives in specifics. "We accelerate development" is abstract, and a hundred firms say it.

The difference is not tone. It is whether the sentence contains anything a reader, human or otherwise, can hold onto.

So run the test before the conversation turns to a rebrand, but hold no illusion that ten minutes fixes anything. The ten minutes only exposes the problem. Resolving it means doing the harder work on the words themselves, which is the work a visual redesign lets a company skip while changing nothing that was wrong.